{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:51:54Z","timestamp":1785880314200,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.sapharm.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:50:07Z","timestamp":1776174607000},"page":"819-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial"],"prefix":"10.1016","volume":"22","author":[{"given":"Hiroshi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Domichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-571X","authenticated-orcid":false,"given":"Naoki","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2026.04.005_bib1","article-title":"Prevention of hypoglycemia by intermittent\u2010scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: a randomized, crossover trial","volume":"195","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jdi.13973","article-title":"Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: the FGM-Japan study","volume":"14","author":"Sakane","year":"2023","journal-title":"J Diabetes Investig"},{"issue":"7","key":"10.1016\/j.sapharm.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","article-title":"Continuous glucose monitoring for the routine care of type 2 diabetes mellitus","volume":"20","author":"Ajjan","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc23-1520","article-title":"Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence","volume":"47","author":"Seidu","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Therapeut"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: a real-world analysis","volume":"23","author":"Perlman","year":"2021","journal-title":"Diabetes Technol Therapeut"},{"issue":"8","key":"10.1016\/j.sapharm.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.sapharm.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2486\/indhealth.45.467","article-title":"Relationship between behavioral lifestyle and mental health status evaluated using the GHQ-28 and SDS questionnaires in Japanese factory workers","volume":"45","author":"Suda","year":"2007","journal-title":"Ind Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1742395319884096","article-title":"Clinical associations of an updated medication effect score for measuring diabetes treatment intensity","volume":"17","author":"Alexopoulos","year":"2021","journal-title":"Chron Illness"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.005_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12875-022-01758-z","article-title":"Psychometric evaluation of the Arabic version of the 5-item Problem Areas in Diabetes (AR-PAID-5) scale","volume":"23","author":"Sayed","year":"2022","journal-title":"BMC Prim Care"},{"issue":"6","key":"10.1016\/j.sapharm.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(00)00095-7","article-title":"Athens insomnia scale: validation of an instrument based on ICD-10 criteria","volume":"48","author":"Soldatos","year":"2000","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.005_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/ijerph15050947","article-title":"Use of diabetes treatment satisfaction questionnaire in diabetes care: importance of patient-reported outcomes","volume":"15","author":"Saisho","year":"2018","journal-title":"Int J Environ Res Publ Health"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jval.2020.11.012","article-title":"An international comparison of EQ-5D-5L and EQ-5D-3L for use in cost-effectiveness analysis","volume":"24","author":"Wailoo","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.sapharm.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/dc22-1219","article-title":"Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: results of the LIBERATES trial","volume":"46","author":"Ajjan","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/dom.14949","article-title":"IMpact of flash glucose monitoring in pEople with type 2 diabetes inadequately controlled with non-insulin antihyperglycaemic thErapy (IMMEDIATE): a randomized controlled trial","volume":"25","author":"Aronson","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/08971900211000273","article-title":"Flash continuous glucose monitoring: a practical guide and call to action for pharmacists","volume":"35","author":"Cowart","year":"2022","journal-title":"J Pharm Pract"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2026.04.005_bib19","first-page":"S146","article-title":"Diabetes technology: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.japh.2021.05.013","article-title":"The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes","volume":"61","author":"Ulrich","year":"2021","journal-title":"J Am Pharmaceut Assoc"},{"issue":"5","key":"10.1016\/j.sapharm.2026.04.005_bib21","first-page":"600","article-title":"Effect of pharmacist-driven professional continuous glucose monitoring in adults with uncontrolled diabetes","volume":"26","author":"Sherrill","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.04.005_bib22","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v15i1.5906","article-title":"Development of a continuous glucose monitoring service by clinical pharmacists in a medically underserved population","volume":"15","author":"Lingow","year":"2024","journal-title":"Innov Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2026.04.005_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090154","article-title":"Impact of real-time glucose monitoring using FreeStyle libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and\/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol","volume":"15","author":"Wilmot","year":"2025","journal-title":"BMJ Open"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:37:43Z","timestamp":1785879463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1551741126000859"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.04.005","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}